Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Clinical trial NCT06911424 · RECRUITING
Trial details
- NCT number
- NCT06911424
- Sponsor
- Baxis Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-21
- Primary completion
- 2026-03-16
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.